NASDAQ:TRVI | Free Cash Flow | Trevi Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$16.69M$102,000.00-$16.79M
2025-12-31-$7.63M$0.00-$7.63M
2025-03-31-$13.48M
2024-12-31-$9.55M$7,000.00-$9.56M
2024-03-31-$10.47M
2023-12-31-$6.36M$22,000.00-$6.38M
2023-03-31-$8.2M$57,000.00-$8.25M
2022-12-31-$6.33M$116,000.00-$6.45M
2022-03-31-$7.09M
2021-12-31-$6.23M
2021-03-31-$7.58M
2020-12-31-$8.92M$5,000.00-$8.93M
2020-03-31-$4.67M
2019-12-31-$6.2M$0.00-$6.2M
2019-03-31-$4.1M$9,000.00-$4.11M
2018-12-31-$4.73M$92,000.00-$4.82M
2018-03-31-$3.95M$57,000.00-$4.01M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$42.09M$12,000.00-$42.1M
2024-12-31-$38.26M$35,000.00-$38.29M
2023-12-31-$31.71M$137,000.00-$31.85M
2022-12-31-$28.18M$159,000.00-$28.33M
2021-12-31-$28.95M
2020-12-31-$29M$32,000.00-$29.03M
2019-12-31-$23.09M$9,000.00-$23.1M
2018-12-31-$18.29M$158,000.00-$18.45M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.